Marathon And Ebix On The List Of Winners And Losers Of Wednesday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are Marathon, Kopin Corporation, and Karyopharm Therapeutics. Rank Financial Asset Price Change Updated (EST) 1 Marathon (MARA) 30.03 11.38% 2023-12-27 12:13:29 2 Kopin Corporation (KOPN) 1.94…

Read More

Canaan And Cyclacel Pharmaceuticals On The List Of Winners And Losers Of Tuesday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are Canaan, ANSYS, and Canopy Growth. Rank Financial Asset Price Change Updated (EST) 1 Canaan (CAN) 3.17 22.87% 2023-12-25 12:15:48 2 ANSYS (ANSS) 357.98 18.08% 2023-12-25…

Read More

FibroGen And BlackBerry On The List Of Winners And Losers Of Friday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are FibroGen, Catalyst Pharmaceuticals, and Globalstar. Rank Financial Asset Price Change Updated (EST) 1 FibroGen (FGEN) 0.68 19.32% 2023-12-21 12:12:15 2 Catalyst Pharmaceuticals (CPRX) 15.90 11.19%…

Read More

Canaan And Argenx SE On The List Of Winners And Losers Of Thursday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are Canaan, Ebix, and Glatfelter. Rank Financial Asset Price Change Updated (EST) 1 Canaan (CAN) 2.88 29.15% 2023-12-20 12:16:04 2 Ebix (EBIX) 2.29 10.12% 2023-12-20 12:11:58…

Read More

Ebix And CorEnergy Infrastructure Trust On The List Of Winners And Losers Of Wednesday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are Ebix, Arcturus Therapeutics, and Aspen Group. Rank Financial Asset Price Change Updated (EST) 1 Ebix (EBIX) 1.83 14.06% 2023-12-19 12:26:59 2 Arcturus Therapeutics (ARCT) 31.83…

Read More

NASDAQ TEST STOCK And Ebix On The List Of Winners And Losers Of Tuesday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are NASDAQ TEST STOCK, Verrica Pharmaceuticals, and Hostess Brands. Rank Financial Asset Price Change Updated (EST) 1 NASDAQ TEST STOCK (ZVZZT) 39.66 106.03% 2023-12-18 09:13:05 2…

Read More

Akerna Corp. And Glory Star New Media Group Holdings Limited On The List Of Winners And Losers Of Saturday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are Akerna Corp., Intellicheck, and Inpixon . Rank Financial Asset Price Change Updated (EST) 1 Akerna Corp. (KERNW) 0.02 82.24% 2023-12-15 14:23:06 2 Intellicheck (IDN) 1.90…

Read More

Canaan And Evelo Biosciences On The List Of Winners And Losers Of Friday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are Canaan, Ebix, and Redfin. Rank Financial Asset Price Change Updated (EST) 1 Canaan (CAN) 1.71 29.5% 2023-12-14 12:16:25 2 Ebix (EBIX) 5.48 19.16% 2023-12-14 12:11:59…

Read More

Baudax Bio And Canopy Growth On The List Of Winners And Losers Of Thursday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are Baudax Bio, Bellerophon Therapeutics, and CleanSpark. Rank Financial Asset Price Change Updated (EST) 1 Baudax Bio (BXRX) 0.03 22.22% 2023-12-13 07:17:06 2 Bellerophon Therapeutics (BLPH)…

Read More